Live Webinar

June 2, 2020 at 10 a.m. CT

Hospital Epidemiologist and Infectious Disease Specialist Dr. Michael Lin of Rush University Medical Center joins Wealth Management CIO Katie Nixon and Senior Healthcare Analyst Erick Noensie for an update on the markets and COVID-19.

Speakers

Katie Nixon Chief Investment Officer, Wealth Management Northern Trust

Katie is an Executive Vice President and Chief Investment Officer for the Wealth Management business at Northern Trust. In that capacity, Katie leads the national investment management practice for Northern Trust’s Wealth Management business from the firm’s Chicago headquarters. Her responsibilities include investment policy development with a particular focus on portfolio construction and implementation. She also directs the investment management activities of over 200 Northern Trust portfolio managers across the firm’s 60+ Wealth Management offices. Katie sits on the Firm’s Investment Policy Committee and Tactical Asset Allocation Committee, and she chairs the Wealth Management Investment Advisory Committee. Katie was selected as one of Private Asset Management’s ‘50 Most Influential Women in Private Wealth’ for 2016.

Prior to joining Northern Trust, Ms. Nixon worked at U.S. Trust Company for eighteen years in several investment related capacities, including Managing Director and Division Manager in the Wealth Management Division in New York, overseeing a group of portfolio managers and client service officers with total combined assets under management in excess of $7 Billion. Ms. Nixon also served on US Trust's Portfolio Policy Committee as well as the Private Equity Investment Committee.

Katie received her B.A. from Wellesley College and her M.B.A. in Finance from New York University, Stern School of Business where she graduated with distinction, Beta Gamma Sigma, and was a Stern Scholar. She has received the designations of both Certified Investment Management Analyst (CIMA®) and Certified Private Wealth Advisor (CPWA®) from the Investment Management Consultants Association. Further, she has been awarded the Chartered Financial Analyst (CFA) designation, and is also a member of the New York Society of Security Analysts and the Investment Management Consultants Association (IMCA).

Erick Noensie Senior Equity Analyst – Healthcare Sector Northern Trust

Erick Noensie is a Vice President at The Northern Trust Company, Chicago, where he covers the healthcare sector as a Senior Equity Analyst. Prior to joining Northern Trust in 2018, Erick was the Sector Head of Healthcare at Calamos Investments where he directed a team covering the healthcare industry.

Prior to that, he was a Portfolio Manager at UBS O’Connor, managing an international healthcare portfolio in London, and also worked as an Analyst at Caxton Associates where he specialized in the biopharmaceutical sector.

Erick began his career in the investment industry as an Associate in equity research at Goldman Sachs and at Thomas Weisel Partners where he covered the biotechnology sector. Erick received a Ph.D. in Medical Genetics from The Johns Hopkins School of Medicine and a B.A. in Biology from Cornell University. 

Dr. Michael Lin, MD, MPH Associate Professor of Medicine, Infectious Disease Hospital Epidemiologist Rush University Medical Center

Michael Lin, MD, MPH, is an infectious diseases physician and Associate Professor of Medicine at Rush University Medical Center in Chicago, Illinois. He serves as a Hospital Epidemiologist with Rush University Medical Center and is a co-investigator with the CDC Prevention Epicenters Program. His long-term research work has focused on the surveillance and control of extensively drug-resistant organisms such as carbapenem-resistant Enterobacteriaceae, and on implementing infection control interventions in hospitals and long-term care facilities. He is deeply involved with the COVID-19 response at Rush and is serving in an advisory role on aspects of COVID-19 response for Illinois Department of Public Health and the CDC.